RxDoctor Payments Data

Marshall Holland, MD

Neurological Surgery · Birmingham, ALNPI 1689011421

Payments from drug & device makers

What this record shows

This record is dominated by grants: $68,636 of the $81,491 with a category attached, or 84.2%. 7 manufacturers reported payments, led by Boston Scientific at 36.8% of the total. Reporting peaked in 2020 at $68,636 and has fallen 85.7% since, to $9,832 in 2025. Among neurological surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,491in general payments, 2019–2025

Across 35 payments — averaging $2328.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$30K
  • Medtronic$28K
  • Abbott$15K
  • Neuroone Medical Technologies Corporation$6K
  • Clearpoint Neuro, Inc.$3K
  • Convatec Inc.$63
  • plus $16 from 1 others

What the payments were for

  • Consulting fees$5,5637%
  • Speaking & faculty fees$2,5003%
  • Grants$68,63684%
  • Travel & lodging$3,3814%
  • Food & beverage$1,4122%

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,491 in reported general payments places this provider in the 95th percentile of 97 neurological surgery providers in Alabama.

See all neurological surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$106,264
Medicare patients
160
Services billed
291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$114

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →